Financhill
Buy
53

QNCX Quote, Financials, Valuation and Earnings

Last price:
$3.53
Seasonality move :
-7.09%
Day range:
$3.34 - $3.68
52-week range:
$0.72 - $4.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
187.22x
Volume:
388.3K
Avg. volume:
941.7K
1-year change:
103.43%
Market cap:
$198.2M
Revenue:
--
EPS (TTM):
-$1.22

Earnings Data

Next earnings date for QNCX
Mar 23
2026
Most recent earnings per share
-$0.25
Missed by $0.03
(Nov 12/2025)
Consensus Estimate
-$0.22
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

QNCX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/23/2026 Q4 -- -- -- -$0.17 --
11/12/2025 Q3 -- -- -$0.25 -$0.22 -$0.03
08/11/2025 Q2 -- -- -$0.34 -$0.23 -$0.11
05/12/2025 Q1 -- -- -$0.34 -$0.23 -$0.11
03/24/2025 Q4 -- -- -$0.28 -$0.10 -$0.18
11/13/2024 Q3 -- -- -$0.13 -$0.10 -$0.03
08/13/2024 Q2 -- -- -$0.64 -- --
05/13/2024 Q1 -- -- -$0.26 -- --
12/31/2023 Q4 -- -- -$0.22 -- --
11/14/2023 Q3 -- -- -$0.15 -- --
08/03/2023 Q2 -- -- -$0.14 -- --
05/15/2023 Q1 -- -- -$0.34 -- --
12/31/2022 Q4 -- -- -$0.15 -- --
11/09/2022 Q3 -- -- -$0.22 -- --
08/09/2022 Q2 -- -- -$0.51 -- --
05/10/2022 Q1 -- -- -$0.72 -- --
12/31/2021 Q4 -- -- -$0.78 -- --
09/30/2021 Q3 -- -- -$0.73 -- --
06/30/2021 Q2 -- -- -$0.74 -- --
03/31/2021 Q1 -- -- -$0.78 -- --
12/31/2020 Q4 -- -- -$0.70 -- --
09/30/2020 Q3 -- -- -$0.73 -- --
06/30/2020 Q2 -- -- -$0.60 -- --
03/31/2020 Q1 -- -- -$0.61 -- --
12/31/2019 Q4 -- -- -$0.46 -- --
09/30/2019 Q3 -- -- -$0.37 -- --
06/30/2019 Q2 -- -- -$0.57 -- --
03/31/2019 Q1 -- -- -$0.21 -- --
12/31/2018 Q4 -- -- -$0.16 -- --
09/30/2018 Q3 -- -- -$0.12 -- --
06/30/2018 Q2 -- -- -$0.14 -- --
03/31/2018 Q1 -- -- -$0.13 -- --

Quince Therapeutics, Inc. Earnings Questions

  • How Much did Quince Therapeutics, Inc. Generate in Revenue Last Quarter?

    Quince Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Quince Therapeutics, Inc. Beat Earnings Last Quarter?

    Quince Therapeutics, Inc. announced earnings per share of -$0.25 which represents a miss of analyst forecast a -$0.22 per share.

  • Is Quince Therapeutics, Inc. Profitable?

    Quince Therapeutics, Inc. reported -$36K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Quince Therapeutics, Inc. EPS Next Year?

    Quince Therapeutics, Inc.'s earnings are forecast to decrease from -$1.31 per share to -$1.08 per share next year representing a decrease of -18.04%.

  • When is Quince Therapeutics, Inc.'s Earnings Date?

    Quince Therapeutics, Inc.'s next earnings date is March 23, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock